Chemokines in cardiovascular risk prediction

Area of Science:

• Cardiovascular Research
• Inflammation and Immunology

Background:

• Inflammation is crucial in the development and stability of atherosclerotic plaques.
• Chemokines are implicated in atherogenesis and plaque destabilization, suggesting potential as therapeutic targets.

Purpose of the Study:

• To evaluate the potential of plasma inflammatory markers, specifically chemokines, as non-invasive diagnostic and predictive tools for coronary artery disease (CAD).
• To assess the suitability of chemokines as biomarkers for cardiovascular disease risk prediction.

Main Methods:

• Review of existing studies on chemokines, their role in atherosclerosis, and their predictive value for cardiac events.
• Analysis of criteria for ideal cardiovascular biomarkers, including upstream inflammatory activity reflection, stable levels, and protein stability.
• Consideration of gene polymorphisms of chemokines and their receptors in relation to atherosclerotic disease prediction.

Main Results:

• Some studies indicate that plasma levels of certain chemokines (e.g., IL-8, MCP-1) may predict future cardiac events, independent of traditional risk factors.
• Gene polymorphisms in chemokine pathways have also shown predictive potential for atherosclerotic disease.
• However, current evidence is insufficient to establish firm conclusions regarding their clinical utility.

Conclusions:

• While associations between chemokines and CAD are demonstrated, further large-scale prospective studies are required.
• Validation in multiple cohorts and clear evidence of incremental prognostic value over existing models are necessary.
• Successful validation could lead to improved risk assessment, diagnosis, prognosis, and treatment monitoring for atherosclerosis.